Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

Table 1 Demographic data of the 19 patients with primary (P) or recurrent (R) ovarian cancer and peritoneal carcinomatosis

No.	Age	Ovarian cancer	Initial FIGO tumor stage	Previous chemotherapy	Progression-free (months)
1	65	P	III	None	0
2	53	R	III	Platinum derivatives	18
3	60	P	III	None	0
4	63	P	III	None	0
5	54	R	III	Platinum derivatives	12
6	36	R	IV	Platinum derivatives	9
7	54	R	III	Platinum derivatives	6
8	44	P	IV	None	0
9	56	P	III	None	0
10	43	P	III	None	0
11	53	R	IV	Taxanes	9
12	61	P	IV	Taxanes and Platinum derivatives	0
13	42	R	IV	Taxanes and platinum derivatives	30
14	50	R	III	Platinum derivatives	36
15	59	R	III	Platinum derivatives	18
16	79	R	III	None	19
17	30	P	III	None	0
18	58	R	III	Platinum derivatives	12
19	73	R	III	Platinum derivatives	18

ISSN: 1477-7819